Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study Howard I Scher, Tomasz M Beer,et al. Lancet 2010;375: 1437–1446
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.